日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Elucidating the Mechanisms of SA-4-1BBL-Mediated Cancer Immunoprevention Through Advanced Informatics Approaches

利用先进的信息学方法阐明SA-4-1BBL介导的癌症免疫预防机制

Verma, Mohit; Arguc, Feyza Nur; Malik, Mohammad T; Singh, Pallav; Dhakal, Sameep; Chan, Yen On; Immadi, Manish Sridhar; Dahal, Sabin; Ulker, Vahap; Tarique, Mohammad; Batra, Lalit; Yolcu, Esma S; Shirwan, Haval; Joshi, Trupti

Intratumoral delivery of 4-1BBL boosts IL-12-triggered anti-glioma immunity.

肿瘤内注射 4-1BBL 可增强 IL-12 触发的抗胶质瘤免疫力。

Lunavat Taral R, Nieland Lisa, van de Looij Sanne M, de Reus Alexandra J E M, Couturier Charles P, El Farran Chadi A, Miller Tyler E, Lill Julia K, Schübel Maryam, Xiao Tianhe, Di Ianni Emilio, Woods Elliot C, Sun Yi, Rufino-Ramos David, van Solinge Thomas S, Mahjoum Shadi, Grandell Emily, Li Mao, Mangena Vamsi, Dunn Gavin P, Jenkins Russell W, Mempel Thorsten R, Breakefield Xandra O, Breyne Koen

A novel feeder cell based on 4-1BBL and membrane-bound IL-21/IL-15 induce highly expansion and anti-tumor effect of natural killer cells

一种基于4-1BBL和膜结合型IL-21/IL-15的新型饲养细胞可诱导自然杀伤细胞的大量扩增和抗肿瘤作用

Gong, Sha; Mei, Nan; Wang, Jun; Zhu, Junsheng; Wang, Lu; Lu, Xiaohong; He, Pengcheng; Chen, Weiwei; Xi, Lei; Bao, Yingying; Wald, David N; Fan, Xiaohu; Wang, Huaiyu

CEA-4-1BBL: CEACAM5-Targeted 4-1BB Ligand Fusion Proteins for Cis Co-Stimulation with CEA-TCB.

CEA-4-1BBL:靶向 CEACAM5 的 4-1BB 配体融合蛋白,用于与 CEA-TCB 进行顺式共刺激。

Claus Christina, Ferrara-Koller Claudia, Sam Johannes, Lang Sabine, Albrecht Rosmarie, Buser Regula B, Bommer Esther, Sala Grégory La, Nicolini Valeria G, Colombetti Sara, Bacac Marina, Umaña Pablo, Klein Christian

Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy

在肿瘤微环境的效应阶段,Batf3+树突状细胞和4-1BB/4-1BBL轴是PD-1/PD-L1阻断疗效所必需的。

Andrea Ziblat ,Brendan L Horton ,Emily F Higgs ,Ken Hatogai ,Anna Martinez ,Jason W Shapiro ,Danny E C Kim ,YuanYuan Zha ,Randy F Sweis ,Thomas F Gajewski

Combining mathematical modeling, in vitro data and clinical target expression to support bispecific antibody binding affinity selection: a case example with FAP-4-1BBL

结合数学建模、体外数据和临床靶点表达来支持双特异性抗体结合亲和力的选择:以FAP-4-1BBL为例

Sanchez, Javier; Claus, Christina; McIntyre, Christine; Tanos, Tamara; Boehnke, Axel; Friberg, Lena E; Jönsson, Siv; Frances, Nicolas

Oncolytic vaccinia virus armed with 4-1BBL elicits potent and safe antitumor immunity and enhances the therapeutic efficiency of PD-1/PD-L1 blockade in a pancreatic cancer model

携带 4-1BBL 的溶瘤痘苗病毒可诱导强效且安全的抗肿瘤免疫,并增强胰腺癌模型中 PD-1/PD-L1 阻断疗法的治疗效果。

Yushi Ju,Feiyu Dai,Yirong Wang,Zhenyu Ye,Yang Li,Songguang Ju,Yan Ge,Wei Chen

The role of IL‑17, IFN‑γ, 4‑1BBL and tumour‑infiltrating lymphocytes in the occurrence, development and prognosis of pancreatic cancer

IL-17、IFN-γ、4-1BBL及肿瘤浸润淋巴细胞在胰腺癌发生、发展及预后中的作用

Yingying Liu, Ke Zhang, Xiaodi Cai, Jikai Zhou, Yixuan Cai, Yujie Gu, Tingting Xia, Jianxin Ye

4-1BB-4-1BBL cis-interaction contributes to the survival of self-reactive CD8(+) T cell

4-1BB-4-1BBL顺式相互作用有助于自身反应性CD8(+) T细胞的存活

Cho, Eunjung; Singh, Rohit; Han, Chungyong; Kim, Seon-Hee; Kim, Kwang H; Park, Bo-Mi; Shin, Dong Hoon; Han, Seongeun; Kim, Young H; Kwon, Byoung S; Nam, Ki Taek; Choi, Beom K

Development of an antibody-ligand fusion protein scFvCD16A-sc4-1BBL in Komagataella phaffii with stimulatory activity for Natural Killer cells

在 Komagataella phaffii 中开发出一种具有刺激自然杀伤细胞活性的抗体-配体融合蛋白 scFvCD16A-sc4-1BBL

Yangyang Li ,Siqi Xie ,Minhua Chen ,Hao Li ,Yehai Wang ,Yan Fan ,Kang An ,Yu Wu ,Weihua Xiao